Monte Rosa Therapeutics, Inc.
GLUE
$16.86
$1.459.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.55% | 10.83% | 69.04% | 60.12% | 35.70% |
| Total Receivables | 734.45% | -75.92% | 134.28% | -65.74% | 102.38% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.61% | 11.15% | -13.44% | 55.37% | 103.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 59.95% | 7.76% | 66.94% | 59.79% | 37.34% |
|
|
|||||
| Total Current Assets | 59.95% | 7.76% | 66.94% | 59.79% | 37.34% |
| Net Property, Plant & Equipment | -10.45% | -10.50% | -10.98% | -10.06% | -8.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.80% | 6.31% | 1.29% | 0.93% | 5.74% |
| Total Assets | 45.94% | 4.50% | 47.41% | 44.44% | 24.98% |
|
|
|||||
| Total Accounts Payable | 264.73% | -13.78% | -4.96% | 54.37% | -27.67% |
| Total Accrued Expenses | 17.78% | 13.39% | 38.73% | 19.35% | 21.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.32% | 17.95% | 15.55% | 17.46% | 26.55% |
| Total Finance Division Other Current Liabilities | 30.77% | -7.75% | 63.94% | 523.22% | 595.36% |
| Total Other Current Liabilities | 30.77% | -7.75% | 63.94% | 523.22% | 595.36% |
| Total Current Liabilities | 47.55% | -1.17% | 43.40% | 236.85% | 84.18% |
|
|
|||||
| Total Current Liabilities | 47.55% | -1.17% | 43.40% | 236.85% | 84.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.30% | -9.41% | -9.17% | -9.04% | -7.96% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 317.59% | -65.16% | -33.04% | -43.35% | 1,822.23% |
| Total Liabilities | 95.22% | -23.39% | 3.34% | 73.32% | 62.21% |
|
|
|||||
| Common Stock & APIC | 3.09% | 3.04% | 21.18% | 21.36% | 27.22% |
| Retained Earnings | 4.63% | 5.64% | 1.55% | -19.87% | -35.89% |
| Treasury Stock & Other | -39.84% | -26.33% | -23.62% | -23.20% | -59.59% |
| Total Common Equity | 19.65% | 19.32% | 80.41% | 24.37% | 11.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.65% | 19.32% | 80.41% | 24.37% | 11.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.65% | 19.32% | 80.41% | 24.37% | 11.34% |
|
|
|||||